Member Info for OAPK20

1hr X

#HEX 🌅Sunrise in Montana. Ingomar nearing completion as our team works through the night.

Rig 704 stands tall with the mast up, readying for re-entry at Clink #1.

Exciting times ahead as we prepare to evaluate its #Helium & #Hydrogen potential.

#MontanaHeliumFairway

1

Https://bogfiles.dnrc.mt.gov/Well_Data/2508721751/2508721751.pdf

Page 12

Estimated target intervals

Amsden-3842’

Charles-4775’

Flathead-7409’

Pre-Cambrian-7750’

Formation Evaluation/Logging plan

Mud logger-3000-8000’

Triple Combo OH-3500-8000’

CBL/GR- 0-8000’

Drilling Plan

Set 16” conductor at 80’ drill 12.25” surface hole to 750’ with FW spud mud. Run/cement 8000’ 5.5” L80 LTC. Large PRODUCTION hole being drilled to allow intermediate 7” casing string to be run if hole issues encountered. Drilling rig to use lined earthen pit to contain drill cuttings. After drilling completed residual water in pit will be allowed to evaporate before liner is wrapped and cuttings buried on site.

Completion

After evaluating open hole logs and correlating to cased hole logs well will be perforated with 4 SPF guns and each target interval will be isolated for PRODUCTION testing (treated w/15% HCI if necessary). If well determined to be non-commercial P&A process will commence following MBOGC guidelines.

Page 16

Construction timeframe - July 16th 2024 to December 31st 2025 ; Temporary (

Only newbie thing is the new name

Not shorting. Don’t short. Never shorted. Too risky.

Post after post after post

Current status of Doug’s lease ? Expired, extended , TBC? Remaining leases. Talks ongoing?

Assuming the well integrity remains intact and it proves commercial will HEX take the opportunity to acquire further funding?

“Further funding will be required to implement the Company’s helium development and distribution plans which, in aggregate, will require approximately US$20 million (including up to US$15 million for the Company’s first plant site which would aim to deliver approximately 55,500 Mcf of helium per year). The Company may look to implement lease financing arrangements which will reduce the upfront capital expenditure relating to the construction of the plant.”

Search any thread you’ll find the same garbage posted by the many different “newbie” posters.

Just need the “I’m raising money for my mates [ fill in life threatening ailment ] blah blah.

Newbie broker accounts. Yep. Pump it up for the mates rates discount. Drilling might be funded for now but the next stage isn’t.

Even the Telegram pumpers are quiet. Watch out for forward selling

New accounts, new tweets, guess what that means.

Dirty

Good tech hope you’re well. You have a re entry in mind here. Lower on the cards possibly.

Is back to 5p on the cards again?

Funding going forward ? Will FDA approval arrive before the need to raise ?

“FDA 'De Novo' completion of substantive review. Ongoing FDA discussions regarding additional information“

The US Food and Drug Administration (FDA) De-Novo submission for CARDIO inCode-Score was filed in November 2023 and the FDA has recently completed its substantive review. Whilst the FDA submission and review process has been protracted and longer than expected, discussions remain progressive and constructive. The FDA have requested additional information as part of their review of the CARDIO inCode-Score medical device and we anticipate this should finalise the review process. We expect to provide this information over the coming months and give a further update towards the end of this year. Approval of CARDIO inCode-Score will extend our US commercial offering enabling laboratory testing across the US.

Financial review

Revenue for the period was £1.39m (H1 2023: £0.95m), a year-on-year increase of 46%, with a reduced Adjusted EBITDA loss of (£2.16m) (H1 2023: (£3.37m)), the decreased loss resulting from improving revenues and profit margins coupled with lower operational costs across the Group.

Revenue

Spain continues to be the largest region for sales and enjoyed a year-on-year growth of 21%. Sales in the UK increased to £328k (H1 2023: £131k), reflecting the full six-month revenue benefit of LIPID inCode® sales to the NHS effective from May 2023.

The Group enjoyed its first revenues in the US and recognised £71k of LIPID inCode® sales in the period. LIPID inCode® continues to be the leading revenue generating product in the Company, representing over 60% of the sales, boosted by the significant increase in UK sales to the NHS as highlighted above.

Gross profit

Gross profit was £730k (H1 2023: £467k). The gross profit margin increased to 52.6% (H1 2023: 49.2%). Geographically, the gross profit margins generated from Spain remained the same at the sub 50% level, however the Group benefitted from 55%+ margins from the UK sales and 70%+ margins from the US sales.

Page 17

In the case of a successful well

If the well is successful and is transitioned to commercial production, a buried pipeline and buried power line will be installed after July 15th 2025. Additionally the 5.84 acre production facility will be constructed. The temporary 2.05 acre well pad will be reclaimed to a 0.23 acre PRODUCTION well pad.

The only infrastructure on the well pad during production will be a well head. All other associated infrastructure will be stored within the PRODUCTION facility.

Page 21

Seasonal use

As authorised by permitting agency or agencies activities will be prohibited from March 15th through July 15th outside of the perimeter of an active lek in Core areas where breeding, nesting and early brood-rearing habitat is present.

To get a placing away is the rumour staring in TG.

Hope not but there’s previous with a certain person….

🎰

Held. 31250000- Late SELL from 16th of 3,388,780 shares.